New Enterprise Associates 17, L.P.

Insider Reports History

Location
Timonium, MD
Signature
/s/ Zachary Bambach, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by New Enterprise Associates 17, L.P.:

Company Role Class Num Shares Value Price $ Report Date Ownership
SpyGlass Pharma, Inc. 10%+ Owner Common Stock 6,035,038 $167,955,108 $27.83 09 Feb 2026 Direct
Monte Rosa Therapeutics, Inc. 10%+ Owner Common Stock 7,692,298 $146,153,662 $19.00 28 Jun 2021 Direct
MBX Biosciences, Inc. 10%+ Owner Common Stock 3,614,486 $38,638,855 $10.69 16 Sep 2024 Direct
Korro Bio, Inc. 10%+ Owner Common Stock 1,297,893 $14,419,591 $11.11 10 Mar 2026 Direct
NeueHealth, Inc. Director, 10%+ Owner Common Stock 0 $0 $6.84 02 Oct 2025 Direct
Korro Bio, Inc. 10%+ Owner Pre-Funded Warrants 242,945 10 Mar 2026 Direct
MBX Biosciences, Inc. 10%+ Owner Series A Convertible Preferred Stock 0 16 Sep 2024 Direct
MBX Biosciences, Inc. 10%+ Owner Series B Convertible Preferred Stock 0 16 Sep 2024 Direct
Monte Rosa Therapeutics, Inc. 10%+ Owner Series A-2 convertible preferred stock 0 28 Jun 2021 Direct
Monte Rosa Therapeutics, Inc. 10%+ Owner Series B convertible preferred stock 0 $2.00 28 Jun 2021 Direct
Monte Rosa Therapeutics, Inc. 10%+ Owner Series C convertible preferred Stock 0 28 Jun 2021 Direct
NeueHealth, Inc. Director, 10%+ Owner Series A Convertible Perpetual Preferred Stock 0 02 Oct 2025 Direct
NeueHealth, Inc. Director, 10%+ Owner Series B Convertible Perpetual Preferred Stock 0 02 Oct 2025 Direct
NeueHealth, Inc. Director, 10%+ Owner Warrant (Right to Buy) 0 02 Oct 2025 Direct
SpyGlass Pharma, Inc. 10%+ Owner Series B Preferred Stock 0 09 Feb 2026 Direct
SpyGlass Pharma, Inc. 10%+ Owner Series C-1 Preferred Stock 0 09 Feb 2026 Direct
SpyGlass Pharma, Inc. 10%+ Owner Series C-2 Preferred Stock 0 09 Feb 2026 Direct
SpyGlass Pharma, Inc. 10%+ Owner Series D Preferred Stock 0 09 Feb 2026 Direct

Insider Reports Filed by New Enterprise Associates 17, L.P.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KRRO Korro Bio, Inc. 10 Mar 2026 2 +$2,300,881 4 10%+ Owner 12 Mar 2026, 20:15
SGP SpyGlass Pharma, Inc. 09 Feb 2026 9 +$15,000,000 4 10%+ Owner 11 Feb 2026, 16:30
SGP SpyGlass Pharma, Inc. 05 Feb 2026 0 $0 3 10%+ Owner 05 Feb 2026, 16:05
NEUE NeueHealth, Inc. 02 Oct 2025 10 +$0.23 4 Director, 10%+ Owner 06 Oct 2025, 17:49
NEUE NeueHealth, Inc. 01 Oct 2024 1 $0 4 10%+ Owner 03 Oct 2024, 18:15
MBX MBX Biosciences, Inc. 16 Sep 2024 5 +$8,000,000 4 10%+ Owner 17 Sep 2024, 20:12
MBX MBX Biosciences, Inc. 12 Sep 2024 0 $0 3 10%+ Owner 12 Sep 2024, 19:19
KRRO Korro Bio, Inc. 22 Apr 2024 1 +$999,992 4 10%+ Owner 24 Apr 2024, 17:00
NEUE NeueHealth, Inc. 08 Apr 2024 1 $0 4 10%+ Owner 10 Apr 2024, 18:46
KRRO Korro Bio, Inc. 03 Nov 2023 0 $0 3 10%+ Owner 07 Nov 2023, 21:25
NEUE Bright Health Group Inc. 17 Oct 2022 0 $0 3/A 10%+ Owner 20 Oct 2022, 16:37
GLUE Monte Rosa Therapeutics, Inc. 28 Jun 2021 7 +$19,950,000 4 10%+ Owner 30 Jun 2021, 17:59
GLUE Monte Rosa Therapeutics, Inc. 23 Jun 2021 0 $0 3 10%+ Owner 23 Jun 2021, 21:00